Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Sexually Transmitted Diseases

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 250 articles:
HTML format

Single Articles

    January 2024
  1. DOS SANTOS LM, Vieira MRMDS, Vieira RC, Silva LBDL, et al
    Prevalence and circulant genotypes of Chlamydia trachomatis in university women from cities in the Brazilian Amazon.
    PLoS One. 2024;19:e0287119.
    PubMed     Abstract available

  2. SETIAWAN D, Nurulita NA, Khoirunnisa SM, Postma MJ, et al
    The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women.
    PLoS One. 2024;19:e0290808.
    PubMed     Abstract available

  3. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    PubMed     Abstract available

  4. MBOUMBA BOUASSA RS, Avala Ntsigouaye J, Lemba Tsimba PC, Nodjikouambaye ZA, et al
    Genetic diversity of HPV35 in Chad and the Central African Republic, two landlocked countries of Central Africa: A cross-sectional study.
    PLoS One. 2024;19:e0297054.
    PubMed     Abstract available

  5. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    PubMed     Abstract available

  6. KANG SW, Kang OJ, Lee JY, Kim H, et al
    Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    PLoS One. 2024;19:e0298815.
    PubMed     Abstract available

  7. YAO B, Peng J, Song W, Yang L, et al
    Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
    PLoS One. 2024;19:e0299651.
    PubMed     Abstract available

  8. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
    Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
    PLoS One. 2024;19:e0292605.
    PubMed     Abstract available

  9. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    PubMed     Abstract available

  10. MIRZADEH P, Oye-Somefun A, Ardern CI, Buick CJ, et al
    Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
    PLoS One. 2024;19:e0299479.
    PubMed     Abstract available

  11. BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al
    High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
    PLoS One. 2024;19:e0298583.
    PubMed     Abstract available

  12. HAMILL MM, Onzia A, Parkes-Ratanshi RM, Kyambadde P, et al
    Antibiotic overuse, poor antimicrobial stewardship, and low specificity of syndromic case management in a cross section of men with urethral discharge syndrome in Kampala, Uganda.
    PLoS One. 2024;19:e0290574.
    PubMed     Abstract available

  13. KOMORI A, Mori H, Xie W, Valenti S, et al
    Rapid resurgence of syphilis in Japan after the COVID-19 pandemic: A descriptive study.
    PLoS One. 2024;19:e0298288.
    PubMed     Abstract available

  14. CECCARANI C, Gaspari V, Morselli S, Djusse ME, et al
    Chlamydia trachomatis and Neisseria gonorrhoeae rectal infections: Interplay between rectal microbiome, HPV infection and Torquetenovirus.
    PLoS One. 2024;19:e0301873.
    PubMed     Abstract available

  15. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    PubMed     Abstract available

  16. DU-THANH A, Foulongne V, Dereure O, Eloit M, et al
    A quantitative assay for the assessment of cutaneous human papillomaviruses and polyomaviruses over time: A proof-of-concept in two patients with atopic dermatitis and psoriasis.
    PLoS One. 2024;19:e0297907.
    PubMed     Abstract available

    January 2023
  17. ABUKU VG, Allotey EA, Akonde M
    Clinical and laboratory presentation of first-time antenatal care visits of pregnant women in Ghana, a hospital-based study.
    PLoS One. 2023;18:e0280031.
    PubMed     Abstract available

  18. BUNTING SR, Morris S, Chael J, Feinstein BA, et al
    Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students.
    PLoS One. 2023;18:e0280287.
    PubMed     Abstract available

  19. BEDNO S, Hakre S, Clark S, Dear N, et al
    Prospective screening for sexually transmitted infections among US service members with Chlamydia trachomatis or Neisseria gonorrhoeae infection.
    PLoS One. 2023;18:e0280783.
    PubMed     Abstract available

  20. VILLAVICENCIO A, Kelsey G, Nogueira NF, Zukerberg J, et al
    Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US.
    PLoS One. 2023;18:e0275141.
    PubMed     Abstract available

  21. OKIRIA AG, Achut V, McKeever E, Bolo A, et al
    High HIV and syphilis prevalence among female sex workers and sexually exploited adolescents in Nimule town at the border of South Sudan and Uganda.
    PLoS One. 2023;18:e0266795.
    PubMed     Abstract available

  22. DE FOUW M, Stroeken Y, Niwagaba B, Musheshe M, et al
    Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda.
    PLoS One. 2023;18:e0280052.
    PubMed     Abstract available

  23. AMBAYE E, Ormago MD, Ali MM
    Sero-prevalence and associated factors of sexually transmitted infections among youth-friendly services Attendees.
    PLoS One. 2023;18:e0279900.
    PubMed     Abstract available

  24. NARTEY Y, Amo-Antwi K, Hill PC, Dassah ET, et al
    Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    PLoS One. 2023;18:e0280437.
    PubMed     Abstract available

  25. NASRALLAH GK, Al-Buainain R, Younes N, Dargham SR, et al
    Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations.
    PLoS One. 2023;18:e0278079.
    PubMed     Abstract available

  26. FLEIDER LA, de Los Angeles Tinnirello M, Gomez Cherey F, Garcia MG, et al
    High sensitivity and specificity rates of cobas(R) HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting.
    PLoS One. 2023;18:e0279728.
    PubMed     Abstract available

    Blood-borne infections and pregnancies among women attending a sexual violence assistance center in Brazil: A 10-year retrospective study.
    PLoS One. 2023;18:e0280419.
    PubMed     Abstract available

  28. WONGJAMPA W, Nakahara T, Tanaka K, Yugawa T, et al
    An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16.
    PLoS One. 2023;18:e0281069.
    PubMed     Abstract available

  29. LEE RH, Roy R, Li H, Hechmer A, et al
    Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts.
    PLoS One. 2023;18:e0282177.
    PubMed     Abstract available

  30. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
    Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    PLoS One. 2023;18:e0282853.
    PubMed     Abstract available

  31. GARCIA LUNA JA, Romero-Rosas N, Silva Pena SA, Oviedo Sarmiento OJ, et al
    Diagnostic performance of two rapid tests for syphilis screening in people living with HIV in Cali, Colombia.
    PLoS One. 2023;18:e0282492.
    PubMed     Abstract available

  32. BOGERS S, Schim van der Loeff M, Boyd A, van Dijk N, et al
    Improving provider-initiated testing for HIV and other STI in the primary care setting in Amsterdam, the Netherlands: Results from a multifaceted, educational intervention programme.
    PLoS One. 2023;18:e0282607.
    PubMed     Abstract available

  33. EDMONDSON DG, De Lay BD, Hanson BM, Kowis LE, et al
    Clonal isolates of Treponema pallidum subsp. pallidum Nichols provide evidence for the occurrence of microevolution during experimental rabbit infection and in vitro culture.
    PLoS One. 2023;18:e0281187.
    PubMed     Abstract available

  34. BHATTA M, Majumdar A, Ghosh U, Ghosh P, et al
    Sexually transmitted infections among key populations in India: A protocol for systematic review.
    PLoS One. 2023;18:e0279048.
    PubMed     Abstract available

  35. LUGO LZA, Puga MAM, Jacob CMB, Padovani CTJ, et al
    Cytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus.
    PLoS One. 2023;18:e0279390.
    PubMed     Abstract available

  36. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    PubMed     Abstract available

  37. GIBSON-HELM M, Slater T, MacDonald EJ, Stevenson K, et al
    Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    PLoS One. 2023;18:e0280643.
    PubMed     Abstract available

  38. SMITH JS, Vaz OM, Gaber CE, Des Marais AC, et al
    Recruitment strategies and HPV self-collection return rates for under-screened women for cervical cancer prevention.
    PLoS One. 2023;18:e0280638.
    PubMed     Abstract available

  39. SHIN HI, Cho KJ, Kim MS, Joo YH, et al
    Predictive factors of distant metastasis in surgically treated HPV-positive tonsil cancer.
    PLoS One. 2023;18:e0283368.
    PubMed     Abstract available

  40. ZHU W, Cardenas-Alvarez MX, Tomberg J, Little MB, et al
    Commensal Neisseria species share immune suppressive mechanisms with Neisseria gonorrhoeae.
    PLoS One. 2023;18:e0284062.
    PubMed     Abstract available

  41. BOBADILLA ML, Villagra V, Ortiz V, Deluca G, et al
    High prevalence and co-infection of high-risk Human Papillomavirus genotypes among unvaccinated young women from Paraguay.
    PLoS One. 2023;18:e0283542.
    PubMed     Abstract available

  42. WEATHERLY M, Trivedi A, Chembrolu R, Gupta S, et al
    Maternal infections in pregnancy and the risk of sudden unexpected infant death in the offspring in the U.S., 2011-2015.
    PLoS One. 2023;18:e0284614.
    PubMed     Abstract available

  43. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    PubMed     Abstract available

  44. BRAUTIGAM CA, Deka RK, Tso SC, Liu WZ, et al
    Biophysical and biochemical studies support TP0094 as a phosphotransacetylase in an acetogenic energy-conservation pathway in Treponema pallidum.
    PLoS One. 2023;18:e0283952.
    PubMed     Abstract available

  45. TEIXEIRA IV, da Silva Leite MT, de Morais Melo FL, da Silva Rocha E, et al
    Predicting congenital syphilis cases: A performance evaluation of different machine learning models.
    PLoS One. 2023;18:e0276150.
    PubMed     Abstract available

  46. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
    Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    PLoS One. 2023;18:e0286202.
    PubMed     Abstract available

  47. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    PLoS One. 2023;18:e0286909.
    PubMed     Abstract available

  48. MONTEIRO IP, Azzi CFG, Bilibio JP, Monteiro PS, et al
    Prevalence of sexually transmissible infections in adolescents treated in a family planning outpatient clinic for adolescents in the western Amazon.
    PLoS One. 2023;18:e0287633.
    PubMed     Abstract available

  49. DUBE MANDISHORA RS, Rounge TB, Fitzpatrick M, Christiansen IK, et al
    Correction: Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
    PLoS One. 2023;18:e0288418.
    PubMed     Abstract available

  50. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    PubMed     Abstract available

  51. NAMBUSI K, Gbolahan A, Maureen SM, Tsholofelo RT, et al
    Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
    PLoS One. 2023;18:e0288971.
    PubMed     Abstract available

  52. WULANDARI D, Meidyandra RW, Andrijono
    Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
    PLoS One. 2023;18:e0287399.
    PubMed     Abstract available

  53. ROYTRAKUL S, Sangprasert P, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcode of multidrug-resistant strains of Neisseria gonorrhoeae isolated from patients in Thailand.
    PLoS One. 2023;18:e0289308.
    PubMed     Abstract available

  54. CONTRERAS NE, Roldan JS, Castillo DS
    Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
    PLoS One. 2023;18:e0290088.
    PubMed     Abstract available

  55. HU H, Jiang H, Zhu Z, Yin H, et al
    Analysis of the anatomical distribution of HPV genotypes in head and neck squamous papillomas.
    PLoS One. 2023;18:e0290004.
    PubMed     Abstract available

  56. SUNGUYA B, Mboya EA, Mizinduko M, Balandya B, et al
    Epidemiology of syphilis infections among pregnant women in Tanzania: Analysis of the 2020 national representative sentinel surveillance.
    PLoS One. 2023;18:e0285069.
    PubMed     Abstract available

  57. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
    Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
    PLoS One. 2023;18:e0286889.
    PubMed     Abstract available

  58. IKEUCHI K, Fukushima K, Tanaka M, Yajima K, et al
    Changes in rapid plasma reagin titers in patients with syphilis before and after treatment: A retrospective cohort study in an HIV/AIDS referral hospital in Tokyo.
    PLoS One. 2023;18:e0292044.
    PubMed     Abstract available

  59. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    PubMed     Abstract available

  60. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
    The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
    PLoS One. 2023;18:e0291725.
    PubMed     Abstract available

  61. AYINDE O, Ross JDC, Jackson L
    Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    PLoS One. 2023;18:e0292273.
    PubMed     Abstract available

  62. BENNETT CL, Detsky AS, Clay CE, Espinola JA, et al
    Comparison of US emergency departments by HIV priority jurisdiction designation: A case for geographically targeted screening in teaching hospitals.
    PLoS One. 2023;18:e0292869.
    PubMed     Abstract available

  63. GU H, Li T, Beeraka NM, Zheng Y, et al
    Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature.
    PLoS One. 2023;18:e0286414.
    PubMed     Abstract available

  64. FEODOROVA VA, Zaitsev SS, Lyapina AM, Kichemazova NV, et al
    Whole genome sequencing characteristics of Chlamydia psittaci caprine AMK-16 strain, a promising killed whole cell veterinary vaccine candidate against chlamydia infection.
    PLoS One. 2023;18:e0293612.
    PubMed     Abstract available

  65. BOZICEVIC I, Blazic TN, Kosanovic Licina ML, Marijan T, et al
    Knowledge about and prevalence of Chlamydia trachomatis in a population-based sample of emerging Croatian adults.
    PLoS One. 2023;18:e0293224.
    PubMed     Abstract available

  66. MAHUMUD RA, Alam K, Afroz S, Ormsby GM, et al
    Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
    PLoS One. 2023;18:e0294379.
    PubMed     Abstract available

  67. PEPIOT A, Supervie V, Breban R
    Impact of voluntary testing on infectious disease epidemiology: A game theoretic approach.
    PLoS One. 2023;18:e0293968.
    PubMed     Abstract available

  68. ZHAO X, Gopalappa C
    Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
    PLoS One. 2023;18:e0288141.
    PubMed     Abstract available

  69. HARRYPARSAD R, Meyer B, Taku O, Serrano M, et al
    Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
    PLoS One. 2023;18:e0294285.
    PubMed     Abstract available

  70. KYEGOMBE N, Ajibola G, Sakoi-Mosetlhi M, Rebatenne T, et al
    Correction: Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
    PLoS One. 2023;18:e0295779.
    PubMed     Abstract available

  71. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    PubMed     Abstract available

  72. LOEHRER S, Hagenbuch F, Marti H, Pesch T, et al
    Longitudinal study of Chlamydia pecorum in a healthy Swiss cattle population.
    PLoS One. 2023;18:e0292509.
    PubMed     Abstract available

  73. BLAYLOCK JM, Ewers EC, Bianchi EJ, King DB, et al
    Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis use.
    PLoS One. 2023;18:e0296054.
    PubMed     Abstract available

    January 2022
  74. MIYAJI KT, Infante V, Picone CM, Levi JE, et al
    Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil.
    PLoS One. 2022;17:e0262724.
    PubMed     Abstract available

  75. PACIENCIA FMD, Chuma IS, Lipende IF, Knauf S, et al
    Female post-copulatory behavior in a group of olive baboons (Papio anubis) infected by Treponema pallidum.
    PLoS One. 2022;17:e0261894.
    PubMed     Abstract available

  76. GRIESHABER NA, Chiarelli TJ, Appa CR, Neiswanger G, et al
    Translational gene expression control in Chlamydia trachomatis.
    PLoS One. 2022;17:e0257259.
    PubMed     Abstract available

  77. MBAH CE, Jasani A, Aaron KJ, Akoachere JF, et al
    Association between Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis and Secondary Infertility in Cameroon: A case-control study.
    PLoS One. 2022;17:e0263186.
    PubMed     Abstract available

  78. SAMJI H, Hu J, Otterstatter M, Hull M, et al
    Gay, bisexual, and other men who have sex with men accessing STI clinics: Optimizing HIV PrEP implementation.
    PLoS One. 2022;17:e0261705.
    PubMed     Abstract available

  79. BUGALHAO JN, Luis MP, Pereira IS, da Cunha M, et al
    The Chlamydia trachomatis inclusion membrane protein CT006 associates with lipid droplets in eukaryotic cells.
    PLoS One. 2022;17:e0264292.
    PubMed     Abstract available

  80. PACHO A, Harding-Esch EM, Heming De-Allie EG, Phillips L, et al
    Facilitators and barriers for clinical implementation of a 30-minute point-of-care test for Neisseria gonorrhoeae and Chlamydia trachomatis into clinical care: A qualitative study within sexual health services in England.
    PLoS One. 2022;17:e0265173.
    PubMed     Abstract available

  81. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    PubMed     Abstract available

  82. ABDULLAHI A, Nzou SM, Kikuvi G, Mwau M, et al
    Neisseria gonorrhoeae infection in female sex workers in an STI clinic in Nairobi, Kenya.
    PLoS One. 2022;17:e0263531.
    PubMed     Abstract available

  83. DAO T, Mun S, Korontsvit T, Khan AG, et al
    A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A*02:01 complex.
    PLoS One. 2022;17:e0265534.
    PubMed     Abstract available

  84. SALARIA D, Rolta R, Mehta J, Awofisayo O, et al
    Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach.
    PLoS One. 2022;17:e0265420.
    PubMed     Abstract available

  85. RUANGTRAGOOL L, Silver R, Machiha A, Gwanzura L, et al
    Factors associated with active syphilis among men and women aged 15 years and older in the Zimbabwe Population-based HIV Impact Assessment (2015-2016).
    PLoS One. 2022;17:e0261057.
    PubMed     Abstract available

  86. CHAW L, Lee SHF, Ja'afar NIH, Lim E, et al
    Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    PLoS One. 2022;17:e0262213.
    PubMed     Abstract available

  87. EDWARDS RJ, Mohammed A, Lavia LO, Edwards J, et al
    Correlates of prevalent syphilis infection among men who have sex with men (MSM) living with HIV attending the HIV clinic in Trinidad.
    PLoS One. 2022;17:e0265909.
    PubMed     Abstract available

  88. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    PubMed     Abstract available

  89. SAKAMOTO J, Saito M, Zhang S, Takakura M, et al
    Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction.
    PLoS One. 2022;17:e0265996.
    PubMed     Abstract available

  90. D S P, Chaturvedi PK, Krishnamoorthy D, Seo YS, et al
    Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
    PLoS One. 2022;17:e0266532.
    PubMed     Abstract available

  91. LIU H, Tang K, Pham CD, Schmerer M, et al
    Characterization of a Neisseria gonorrhoeae Ciprofloxacin panel for an antimicrobial resistant Isolate Bank.
    PLoS One. 2022;17:e0264149.
    PubMed     Abstract available

  92. HASICK N, Kim RR, Xu Y, Bone S, et al
    PlexProbes enhance qPCR multiplexing by discriminating multiple targets in each fluorescent channel.
    PLoS One. 2022;17:e0263329.
    PubMed     Abstract available

  93. JIAMSIRI S, Rhee C, Ahn HS, Poudyal N, et al
    A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand.
    PLoS One. 2022;17:e0267294.
    PubMed     Abstract available

  94. RIGHOLT CH, Willows K, Kliewer EV, Mahmud SM, et al
    Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    PLoS One. 2022;17:e0267646.
    PubMed     Abstract available

  95. ELHASSANNY AEM, Abutaleb NS, Seleem MN
    Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection.
    PLoS One. 2022;17:e0266764.
    PubMed     Abstract available

  96. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    PubMed     Abstract available

  97. AL-MASLAMANI M, Elmagboul EBI, Puthiyottil A, Chemaitelly H, et al
    First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
    PLoS One. 2022;17:e0264737.
    PubMed     Abstract available

  98. ALI A, Rumbold AR, Kapellas K, Lassi ZS, et al
    Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study.
    PLoS One. 2022;17:e0265840.
    PubMed     Abstract available

  99. VAN NIEKERK JM, van Loo IHM, Lucchesi M, Morre SA, et al
    Direct assessment of possible mutations in the 23S rRNA gene encoding macrolide resistance in Chlamydia trachomatis.
    PLoS One. 2022;17:e0265229.
    PubMed     Abstract available

  100. TAYLOR MM, Wi T, Gerbase A, Thwin SS, et al
    Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021).
    PLoS One. 2022;17:e0263550.
    PubMed     Abstract available

  101. LEMMET T, Cotte L, Allavena C, Huleux T, et al
    High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat'AIDS cohort.
    PLoS One. 2022;17:e0268670.
    PubMed     Abstract available

  102. BROUWER AF, Campredon LP, Walline HM, Marinelli BM, et al
    Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study.
    PLoS One. 2022;17:e0268104.
    PubMed     Abstract available

  103. DUFEIL E, Kenfack B, Tincho E, Fouogue J, et al
    Addition of digital VIA/VILI to conventional naked-eye examination for triage of HPV-positive women: A study conducted in a low-resource setting.
    PLoS One. 2022;17:e0268015.
    PubMed     Abstract available

  104. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    PubMed     Abstract available

  105. MCHARO RD, Kisinda A, Njovu L, Mcharo M, et al
    Prevalence of and risk factors associated with HIV, Herpes Simplex Virus-type 2, Chlamydia trachomatis and Neisseria gonorrhoeae infections among 18-24 year old students attending Higher Learning Institutions in Mbeya-Tanzania.
    PLoS One. 2022;17:e0266596.
    PubMed     Abstract available

  106. KAUFMAN E, Williamson T, Mayrand MH, Burchell AN, et al
    Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV.
    PLoS One. 2022;17:e0268521.
    PubMed     Abstract available

  107. PATRICK L, Bakeera-Kitaka S, Rujumba J, Malande OO, et al
    Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
    PLoS One. 2022;17:e0269655.
    PubMed     Abstract available

  108. LENDADO TA, Tekle T, Dawit D, Daga WB, et al
    Determinants of syphilis infection among pregnant women attending antenatal care in hospitals of Wolaita zone, Southern Ethiopia, 2020.
    PLoS One. 2022;17:e0269473.
    PubMed     Abstract available

  109. GENET A, Dagnew Z, Melkie G, Keleb A, et al
    Prevalence of active trachoma and its associated factors among 1-9 years of age children from model and non-model kebeles in Dangila district, northwest Ethiopia.
    PLoS One. 2022;17:e0268441.
    PubMed     Abstract available

  110. SRIPAN P, Pongnikorn D, Chitapanarux I, Tangmunkongvorakul A, et al
    Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: A population-based study.
    PLoS One. 2022;17:e0270670.
    PubMed     Abstract available

  111. KIM M, Kim J, Park NJ, Park JY, et al
    Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
    PLoS One. 2022;17:e0267836.
    PubMed     Abstract available

  112. GIRMA S, Amogne W
    Investigating latent syphilis in HIV treatment-experienced Ethiopians and response to therapy.
    PLoS One. 2022;17:e0270878.
    PubMed     Abstract available

  113. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    PubMed     Abstract available

  114. Retraction: Clinical Impact of De-Regulated Notch-1 and Notch-3 in the Development and Progression of HPV-Associated Different Histological Subtypes of Precancerous and Cancerous Lesions of Human Uterine Cervix.
    PLoS One. 2022;17:e0272116.

  115. DOS SANTOS LM, de Souza JD, Mbakwa HA, Nobre AFS, et al
    High prevalence of sexual infection by human papillomavirus and Chlamydia trachomatis in sexually-active women from a large city in the Amazon region of Brazil.
    PLoS One. 2022;17:e0270874.
    PubMed     Abstract available

  116. ZHAI J, Wang L, Qiao X, Zhao J, et al
    Correction: Detection of Neisseria gonorrhoeae and Chlamydia trachomatis infections in pregnant women by multiplex recombinase polymerase amplification.
    PLoS One. 2022;17:e0271836.
    PubMed     Abstract available

  117. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    PubMed     Abstract available

  118. LIU SS, Chan KKL, Wei TN, Tse KY, et al
    Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population.
    PLoS One. 2022;17:e0272721.
    PubMed     Abstract available

  119. CORREA RM, Baena A, Valls J, Colucci MC, et al
    Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
    PLoS One. 2022;17:e0272205.
    PubMed     Abstract available

  120. NOKCHAN N, Wongsurawat T, Jenjaroenpun P, Nitayanon P, et al
    Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
    PLoS One. 2022;17:e0271657.
    PubMed     Abstract available

  121. CHOI KH, Song JH, Hong JH, Lee YS, et al
    Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment.
    PLoS One. 2022;17:e0273059.
    PubMed     Abstract available

  122. YANG Z, Zhang Y, Stubbe-Espejel A, Zhao Y, et al
    Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
    PLoS One. 2022;17:e0270521.
    PubMed     Abstract available

  123. LUBEYA MK, Mwanahamuntu M, Chibwesha C, Mukosha M, et al
    Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2022;17:e0267617.
    PubMed     Abstract available

  124. STERNJAKOB-MARTHALER A, Berko-Gottel B, Rissland J, Schope J, et al
    Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    PLoS One. 2022;17:e0273332.
    PubMed     Abstract available

  125. GALESHI M, Shirafkan H, Yazdani S, Motaghi Z, et al
    Reproductive health needs of Human papillomavirus (HPV) positive women: A systematic review.
    PLoS One. 2022;17:e0266819.
    PubMed     Abstract available

  126. CAYA C, Maheu-Giroux M, Xia Y, Serhir B, et al
    Stopping syphilis transmission in Arctic communities through rapid diagnostic testing: The STAR study protocol.
    PLoS One. 2022;17:e0273713.
    PubMed     Abstract available

  127. D'COSTA B, Lobo R, Sibosado A, Leavy JE, et al
    Evaluation of the Young, Deadly, Syphilis Free multi-media campaign in remote Australia.
    PLoS One. 2022;17:e0273658.
    PubMed     Abstract available

  128. JOUHI L, Sikio J, Suomalainen A, Mroueh R, et al
    Dental health in patients with and without HPV-positive oropharyngeal and tongue cancer.
    PLoS One. 2022;17:e0274813.
    PubMed     Abstract available

  129. KALIFF M, Lillsunde Larsson G, Helenius G, Karlsson MG, et al
    Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Orebro, Sweden.
    PLoS One. 2022;17:e0274825.
    PubMed     Abstract available

  130. SILVA AAO, Leony LM, Souza WV, Freitas NEM, et al
    Spatiotemporal distribution analysis of syphilis in Brazil: Cases of congenital and syphilis in pregnant women from 2001-2017.
    PLoS One. 2022;17:e0275731.
    PubMed     Abstract available

  131. MUTRICY-HUREAU L, Pisoni A, Suarez-Mutis M, Figueira da Silva A, et al
    Sexual and addictive risk behaviors and sexually transmitted infections in illegal gold miners in French Guiana: A multicenter observational study.
    PLoS One. 2022;17:e0272932.
    PubMed     Abstract available

  132. ZENO EE, Brewer NT, Spees LP, Des Marais AC, et al
    Racial and ethnic differences in cervical cancer screening barriers and intentions: The My Body My Test-3 HPV self-collection trial among under-screened, low-income women.
    PLoS One. 2022;17:e0274974.
    PubMed     Abstract available

  133. MEKONNEN J, Kassim J, Ahmed M, Gebeyehu N, et al
    Prevalence of active trachoma and associated factors among children 1-9 years old at Arsi Negele Town, West Arsi Zone, Oromia Regional State, Southern Ethiopia.
    PLoS One. 2022;17:e0273808.
    PubMed     Abstract available

  134. AMUNDSEN E, Haugstvedt A, Skogen V, Berg RC, et al
    Health characteristics associated with chemsex among men who have sex with men: Results from a cross-sectional clinic survey in Norway.
    PLoS One. 2022;17:e0275618.
    PubMed     Abstract available

  135. PACHE B, Balaya V, Mathis J, Hubner M, et al
    Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
    PLoS One. 2022;17:e0276438.
    PubMed     Abstract available

  136. LANNOY LH, Santos PC, Coelho R, Dias-Santos AS, et al
    Gestational and congenital syphilis across the international border in Brazil.
    PLoS One. 2022;17:e0275253.
    PubMed     Abstract available

  137. POLLAK NM, Fais O, Kristoffersen J, Phuthaworn C, et al
    Rapid sample preparation and low-resource molecular detection of hepatopancreatic parvoviruses (HPV) by recombinase polymerase amplification lateral flow detection assay in shrimps (Fenneropenaeus merguiensis).
    PLoS One. 2022;17:e0276164.
    PubMed     Abstract available

  138. KALIBATAS V, Kalibatiene L
    Reducing the risk of transfusion-transmitted infectious disease markers in blood and blood component donations: Movement from remunerated to voluntary, non-remunerated donations in Lithuania from 2013 to 2020.
    PLoS One. 2022;17:e0277650.
    PubMed     Abstract available

  139. BASILETTI JA, Valls J, Poklepovich T, Fellner MD, et al
    Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections.
    PLoS One. 2022;17:e0278117.
    PubMed     Abstract available

  140. AL-SHIBLI K, Mohammed HAL, Maurseth R, Fostervold M, et al
    Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology.
    PLoS One. 2022;17:e0275858.
    PubMed     Abstract available

  141. YASUDA S, Kyozuka H, Endo Y, Kanno A, et al
    Association of Chlamydia trachomatis infection with pregnancy outcomes among Japanese pregnant women: The Japan environment and children's study.
    PLoS One. 2022;17:e0275573.
    PubMed     Abstract available

  142. PETERSON CE, Dykens JA, Weine SM, Holt HK, et al
    Assessing the interrelationship between stigma, social influence, and cervical cancer prevention in an urban underserved setting: An exploratory study.
    PLoS One. 2022;17:e0278538.
    PubMed     Abstract available

  143. DES MARAIS AC, Brewer NT, Knight S, Smith JS, et al
    Patient perspectives on cervical cancer screening interventions among underscreened women.
    PLoS One. 2022;17:e0277791.
    PubMed     Abstract available

  144. MALKIN J, Allen Scott L, Alberga Machado A, Teare G, et al
    Factors influencing human papillomavirus school-based immunization in Alberta: A mixed-methods study protocol.
    PLoS One. 2022;17:e0278472.
    PubMed     Abstract available

  145. DENNINGHOFF V, von Petery F, Fresno C, Galarza M, et al
    Clinical implementation of a cervical cancer screening program via co-testing at a university hospital.
    PLoS One. 2022;17:e0278476.
    PubMed     Abstract available

  146. LAKNEH EA, Mersha EA, Asresie MB, Belay HG, et al
    Knowledge, attitude, and uptake of human papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia.
    PLoS One. 2022;17:e0276465.
    PubMed     Abstract available

  147. OLUSANYA OA, White B, Malik F, Hester KA, et al
    Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
    PLoS One. 2022;17:e0277748.
    PubMed     Abstract available

    Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.
    PLoS One. 2022;17:e0277394.
    PubMed     Abstract available

  149. HASHEMI L, Ormsbee ME, Patel PJ, Nielson JA, et al
    A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism.
    PLoS One. 2022;17:e0278058.
    PubMed     Abstract available

  150. KHOO SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, et al
    Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
    PLoS One. 2022;17:e0278477.
    PubMed     Abstract available

  151. BOSSARD C, Chihana M, Nicholas S, Mauambeta D, et al
    HIV, sexual violence, and termination of pregnancy among adolescent and adult female sex workers in Malawi: A respondent-driven sampling study.
    PLoS One. 2022;17:e0279692.
    PubMed     Abstract available

    January 2021
  152. SONGANE M, Grossmann V
    The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.
    PLoS One. 2021;16:e0244722.
    PubMed     Abstract available

  153. KHOO SP, Shafii MKA, Bhoo-Pathy N, Yap SH, et al
    Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population.
    PLoS One. 2021;16:e0245731.
    PubMed     Abstract available

  154. LUO Z, Ding Y, Yuan J, Tian L, et al
    Predictors of serological cure after penicillin therapy in HIV-negative patients with early syphilis in Shenzhen, China.
    PLoS One. 2021;16:e0245812.
    PubMed     Abstract available

  155. ST-MARTIN G, Viborg PH, Andersen ABT, Andersen B, et al
    Histological outcomes in HPV-screened elderly women in Denmark.
    PLoS One. 2021;16:e0246902.
    PubMed     Abstract available

  156. ALDOSSRI M, Okoronkwo C, Dodd V, Manson H, et al
    Determinants of dentists' readiness to assess HPV risk and recommend immunization: A transtheoretical model of change-based cross-sectional study of Ontario dentists.
    PLoS One. 2021;16:e0247043.
    PubMed     Abstract available

  157. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    PubMed     Abstract available

  158. BRANDENBURGER D, Ambrosino E
    The impact of antenatal syphilis point of care testing on pregnancy outcomes: A systematic review.
    PLoS One. 2021;16:e0247649.
    PubMed     Abstract available

  159. DEVINE A, Vahanian A, Sawadogo B, Zan S, et al
    Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study.
    PLoS One. 2021;16:e0248832.
    PubMed     Abstract available

  160. TEMESGEN MM, Alemu T, Shiferaw B, Legesse S, et al
    Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
    PLoS One. 2021;16:e0248949.
    PubMed     Abstract available

  161. CHAN EYL, Smullin C, Clavijo S, Papp-Green M, et al
    A qualitative assessment of structural barriers to prenatal care and congenital syphilis prevention in Kern County, California.
    PLoS One. 2021;16:e0249419.
    PubMed     Abstract available

  162. MZOBE GF, Ngcapu S, Joubert BC, Sturm WA, et al
    Differential expression of groEL-1, incB, pyk-F, tal, hctA and omcB genes during Chlamydia trachomatis developmental cycle.
    PLoS One. 2021;16:e0249358.
    PubMed     Abstract available

  163. KOVACEVIC G, Milosevic V, Nikolic N, Patic A, et al
    The prevalence of 30 HPV genotypes detected by EUROArray HPV in cervical samples among unvaccinated women from Vojvodina province, Serbia.
    PLoS One. 2021;16:e0249134.
    PubMed     Abstract available

  164. RANDALL A, Teng A, Liang X, Pal S, et al
    A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens.
    PLoS One. 2021;16:e0250317.
    PubMed     Abstract available

  165. JUBAIR L, Lam AK, Fallaha S, McMillan NAJ, et al
    CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice.
    PLoS One. 2021;16:e0223288.
    PubMed     Abstract available

  166. DUBE MANDISHORA RS, Rounge TB, Fitzpatrick M, Christiansen IK, et al
    Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
    PLoS One. 2021;16:e0250426.
    PubMed     Abstract available

  167. ZHAI J, Wang L, Qiao X, Zhao J, et al
    Detection of Neisseria gonorrhoeae and Chlamydia trachomatis infections in pregnant women by multiplex recombinase polymerase amplification.
    PLoS One. 2021;16:e0251119.
    PubMed     Abstract available

  168. VALE DB, Silva MT, Discacciati MG, Polegatto I, et al
    Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.
    PLoS One. 2021;16:e0251688.
    PubMed     Abstract available

  169. FILARDO S, Di Pietro M, Pasqualetti P, Manera M, et al
    In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials.
    PLoS One. 2021;16:e0251075.
    PubMed     Abstract available

  170. MAO SS, Feng SD, Zheng CL, Hu W, et al
    Trends of HIV/Syphilis/HSV-2 seropositive rate and factors associated with HSV-2 infection in men who have sex with men in Shenzhen, China: A retrospective study.
    PLoS One. 2021;16:e0251929.
    PubMed     Abstract available

  171. YOUM Y, Lee B, Kim J
    A measure of centrality in cyclic diffusion processes: Walk-betweenness.
    PLoS One. 2021;16:e0245476.
    PubMed     Abstract available

  172. RIVIERE C, Bell T, Cadot Y, Perodin C, et al
    Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti.
    PLoS One. 2021;16:e0252310.
    PubMed     Abstract available

  173. RAHMAN S, Wathington D, Waterboer T, Pawlita M, et al
    Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.
    PLoS One. 2021;16:e0253005.
    PubMed     Abstract available

  174. RUJUMBA J, Akugizibwe M, Basta NE, Banura C, et al
    Why don't adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers.
    PLoS One. 2021;16:e0253735.
    PubMed     Abstract available

  175. MANNING C, O'Neill C, Clarke IN, Rebec M, et al
    High-resolution genotyping of Lymphogranuloma Venereum (LGV) strains of Chlamydia trachomatis in London using multi-locus VNTR analysis-ompA genotyping (MLVA-ompA).
    PLoS One. 2021;16:e0254233.
    PubMed     Abstract available

  176. DAVIS AP, Maxwell CL, Mendoza H, Crooks A, et al
    Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
    PLoS One. 2021;16:e0254518.
    PubMed     Abstract available

  177. JU X, Canfell K, Howard K, Garvey G, et al
    Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women.
    PLoS One. 2021;16:e0254575.
    PubMed     Abstract available

  178. HOPKINS KL, Jaffer M, Hlongwane KE, Otwombe K, et al
    Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    PLoS One. 2021;16:e0255124.
    PubMed     Abstract available

  179. CLAVE LLAVALL A, de Wildt G, Meza G, Tattsbridge J, et al
    Nurses' and teachers' perceived barriers and facilitators to the uptake of the Human Papilloma Virus (HPV) vaccination program in Iquitos, Peru: A qualitative study.
    PLoS One. 2021;16:e0255218.
    PubMed     Abstract available

  180. CAMBOU MC, Saad E, McBride K, Fuller T, et al
    Maternal HIV and syphilis are not syndemic in Brazil: Hot spot analysis of the two epidemics.
    PLoS One. 2021;16:e0255590.
    PubMed     Abstract available

  181. ARDHAOUI M, Ennaifer E, De Matos Salim AC, Gomez FM, et al
    Nested PCR followed by NGS: Validation and application for HPV genotyping of Tunisian cervical samples.
    PLoS One. 2021;16:e0255914.
    PubMed     Abstract available

  182. SHAH S, Garg S, Heath K, Ofili O, et al
    Estimation of benzathine penicillin G demand for congenital syphilis elimination with adoption of dual HIV/syphilis rapid diagnostic tests in eleven high burden countries.
    PLoS One. 2021;16:e0256400.
    PubMed     Abstract available

  183. OSTENDORF SB, Kampman CJG, Hoebe CJPA, van der Velden J, et al
    Consultation rate and chlamydia positivity among ethnic minority clients at STI clinics in the Netherlands.
    PLoS One. 2021;16:e0247130.
    PubMed     Abstract available

  184. SUNDSTROM K, Lamin H, Dillner J
    Validation of the cobas 6800 human papillomavirus test in primary cervical screening.
    PLoS One. 2021;16:e0247291.
    PubMed     Abstract available

  185. ENBIALE M, Getie A, Haile F, Tekabe B, et al
    Magnitude of syphilis sero-status and associated factors among pregnant women attending antenatal care in Jinka town public health facilities, Southern Ethiopia, 2020.
    PLoS One. 2021;16:e0257290.
    PubMed     Abstract available

  186. MATOVU JKB, Bukenya JN, Kasozi D, Kisaka S, et al
    Sexual-risk behaviours and HIV and syphilis prevalence among in- and out-of-school adolescent girls and young women in Uganda: A cross-sectional study.
    PLoS One. 2021;16:e0257321.
    PubMed     Abstract available

  187. LARSSON FM, Nielsen A, Briones-Vozmediano E, Stjarnfeldt J, et al
    Indifferent, ambiguous, or proactive? Young men's discourses on health service utilization for Chlamydia trachomatis detection in Stockholm, Sweden: A qualitative study.
    PLoS One. 2021;16:e0257402.
    PubMed     Abstract available

  188. KUGUYO O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R, et al
    High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
    PLoS One. 2021;16:e0257324.
    PubMed     Abstract available

  189. VAVALA G, Goldbeck C, Bristow CC, Stafylis C, et al
    Adolescents may accurately self-collect pharyngeal and rectal clinical specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infection.
    PLoS One. 2021;16:e0255878.
    PubMed     Abstract available

  190. LORENZATTI HILES G, Chang KP, Bellile EL, Wang CI, et al
    Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    PLoS One. 2021;16:e0250530.
    PubMed     Abstract available

  191. WALL KM, Nyombayire J, Parker R, Ingabire R, et al
    Etiologies of genital inflammation and ulceration in symptomatic Rwandan men and women responding to radio promotions of free screening and treatment services.
    PLoS One. 2021;16:e0250044.
    PubMed     Abstract available

  192. HAHN DL
    Chlamydia pneumoniae and chronic asthma: Updated systematic review and meta-analysis of population attributable risk.
    PLoS One. 2021;16:e0250034.
    PubMed     Abstract available

  193. PEEL E, Cheng Y, Djordjevic JT, O'Meally D, et al
    Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum.
    PLoS One. 2021;16:e0249658.
    PubMed     Abstract available

  194. NAJIOULLAH F, Dorival MJ, Joachim C, Dispagne C, et al
    Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
    PLoS One. 2021;16:e0257915.
    PubMed     Abstract available

  195. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    PubMed     Abstract available

  196. ZAFAR H, Atif M, Atia-Tul-Wahab, Choudhary MI, et al
    Fucosyltransferase 2 inhibitors: Identification via docking and STD-NMR studies.
    PLoS One. 2021;16:e0257623.
    PubMed     Abstract available

  197. BONIN-JACOB CM, Almeida-Lugo LZ, Puga MAM, Machado AP, et al
    IL-6 and IL-10 in the serum and exfoliated cervical cells of patients infected with high-risk human papillomavirus.
    PLoS One. 2021;16:e0248639.
    PubMed     Abstract available

  198. MARCUS U, Mirandola M, Schink SB, Gios L, et al
    Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men-is it time to re-evaluate STI-screening as a control strategy?
    PLoS One. 2021;16:e0248582.
    PubMed     Abstract available

  199. ARDIZZONE CM, Albritton HL, Lillis RA, Bagnetto CEL, et al
    Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization.
    PLoS One. 2021;16:e0258759.
    PubMed     Abstract available

  200. JONGEN VW, Schim van der Loeff MF, Botha MH, Sudenga SL, et al
    Incidence and risk factors of C. trachomatis and N. gonorrhoeae among young women from the Western Cape, South Africa: The EVRI study.
    PLoS One. 2021;16:e0250871.
    PubMed     Abstract available

  201. MREMI A, Yahaya JJ, Nyindo M, Mollel E, et al
    Transfusion-Transmitted Infections and associated risk factors at the Northern Zone Blood Transfusion Center in Tanzania: A study of blood donors between 2017 and 2019.
    PLoS One. 2021;16:e0249061.
    PubMed     Abstract available

  202. TOUATI A, Herrmann B, Henin N, Laurier-Nadalie C, et al
    Spread of clonal genovar E Chlamydia trachomatis among men who have sex with men.
    PLoS One. 2021;16:e0259274.
    PubMed     Abstract available

  203. GUI T, Chen Z, Chen F
    Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China.
    PLoS One. 2021;16:e0253493.
    PubMed     Abstract available

  204. FARFOUR E, Dimi S, Chassany O, Fouere S, et al
    Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
    PLoS One. 2021;16:e0250557.
    PubMed     Abstract available

  205. ARUMUGAM A, Markham C, Aykar SS, Van Der Pol B, et al
    PrintrLab incubator: A portable and low-cost CO2 incubator based on an open-source 3D printer architecture.
    PLoS One. 2021;16:e0251812.
    PubMed     Abstract available

  206. HERNANDEZ-LOPEZ R, Hermosillo L, Leon-Maldonado L, Velazquez-Cruz R, et al
    Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women.
    PLoS One. 2021;16:e0254946.
    PubMed     Abstract available

  207. MBULAWA ZZA, Somdyala NI, Mabunda SA, Williamson AL, et al
    High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
    PLoS One. 2021;16:e0253074.
    PubMed     Abstract available

  208. CHAIWONGKOT A, Phanuphak N, Pankam T, Bhattarakosol P, et al
    Human papillomavirus 16 L1 gene methylation as a potential biomarker for predicting anal intraepithelial neoplasia in men who have sex with men (MSM).
    PLoS One. 2021;16:e0256852.
    PubMed     Abstract available

  209. OESCHGER TM, Erickson DC
    Visible colorimetric growth indicators of Neisseria gonorrhoeae for low-cost diagnostic applications.
    PLoS One. 2021;16:e0252961.
    PubMed     Abstract available

  210. MAGKANA M, Mentzelopoulou P, Magkana E, Pampanos A, et al
    The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
    PLoS One. 2021;16:e0253045.
    PubMed     Abstract available

  211. JAMISON CD, Greenwood-Ericksen M, Richardson CR, Choi H, et al
    Association between Chlamydia and routine place for healthcare in the United States: NHANES 1999-2016.
    PLoS One. 2021;16:e0251113.
    PubMed     Abstract available

  212. MUNSAMY Y, Seedat RY, Sekee TR, Bester PA, et al
    Complete genome sequence of a HPV31 isolate from laryngeal squamous cell carcinoma and biological consequences for p97 promoter activity.
    PLoS One. 2021;16:e0252524.
    PubMed     Abstract available

  213. HUSAIYIN S, Jiao Z, Yimamu K, Maisaidi R, et al
    ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients.
    PLoS One. 2021;16:e0260915.
    PubMed     Abstract available

  214. SEIBERT BA, Keel MK, Kelly TR, Nilsen RA, et al
    Chlamydia buteonis in birds of prey presented to California wildlife rehabilitation facilities.
    PLoS One. 2021;16:e0258500.
    PubMed     Abstract available

  215. ROSETTIE KL, Joffe JN, Sparks GW, Aravkin A, et al
    Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
    PLoS One. 2021;16:e0260808.
    PubMed     Abstract available

  216. GARVIN L, Vande Voorde R, Dickinson M, Carrell S, et al
    A broad-spectrum cloning vector that exists as both an integrated element and a free plasmid in Chlamydia trachomatis.
    PLoS One. 2021;16:e0261088.
    PubMed     Abstract available

  217. BALEYDIER I, Vassilakos P, Vinals R, Wisniak A, et al
    Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
    PLoS One. 2021;16:e0260776.
    PubMed     Abstract available

  218. CHEMTOB D, Weil C, Hannink Attal J, Hawila E, et al
    HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis.
    PLoS One. 2021;16:e0259168.
    PubMed     Abstract available

  219. FULLER SS, Clarke E, Harding-Esch EM
    Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development.
    PLoS One. 2021;16:e0259593.
    PubMed     Abstract available

  220. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    PubMed     Abstract available

    January 2020
  221. MBUYA W, Mcharo R, Mhizde J, Mnkai J, et al
    Depletion and activation of mucosal CD4 T cells in HIV infected women with HPV-associated lesions of the cervix uteri.
    PLoS One. 2020;15:e0240154.
    PubMed     Abstract available

  222. FOGELBERG S, Clements MS, Pedersen K, Sy S, et al
    Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
    PLoS One. 2020;15:e0239611.
    PubMed     Abstract available

  223. HAKIM AJ, Bolo A, Werner M, Achut V, et al
    High HIV and syphilis prevalence among female sex workers in Juba, South Sudan.
    PLoS One. 2020;15:e0239543.
    PubMed     Abstract available

  224. WOOD GE, Iverson-Cabral SL, Gillespie CW, Lowens MS, et al
    Sequence variation and immunogenicity of the Mycoplasma genitalium MgpB and MgpC adherence proteins during persistent infection of men with non-gonococcal urethritis.
    PLoS One. 2020;15:e0240626.
    PubMed     Abstract available

  225. HELBLE JD, Mann AO, Starnbach MN
    Antigen-specific memory and naive CD4+ T cells following secondary Chlamydia trachomatis infection.
    PLoS One. 2020;15:e0240670.
    PubMed     Abstract available

  226. HUON JF, Gregoire A, Meireles A, Lefebvre M, et al
    Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
    PLoS One. 2020;15:e0234693.
    PubMed     Abstract available

  227. THOMAS S, Carroll JC, Brown MC, Chen Z, et al
    Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis.
    PLoS One. 2020;15:e0237723.
    PubMed     Abstract available

  228. SAKAI A, Tagami M, Kakehashi A, Katsuyama-Yoshikawa A, et al
    Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment.
    PLoS One. 2020;15:e0238120.
    PubMed     Abstract available

  229. ABDELLA S, Moshago Berheto T, Tolera G, Belete W, et al
    Sero-prevalence of transfusion transmittable infections: HIV, Hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: A retrospective study.
    PLoS One. 2020;15:e0241086.
    PubMed     Abstract available

  230. SABA NF, Dinasarapu AR, Magliocca KR, Dwivedi B, et al
    Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One. 2020;15:e0238497.
    PubMed     Abstract available

  231. KHAN MA, Tiwari D, Dongre A, Sadaf, et al
    Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients.
    PLoS One. 2020;15:e0238500.
    PubMed     Abstract available

  232. SO KA, Yang EJ, Kim NR, Hong SR, et al
    Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection.
    PLoS One. 2020;15:e0238705.
    PubMed     Abstract available

  233. LI WG, Cai CH, Cai XC, Chen SC, et al
    Enhancing gonorrhea surveillance in China by testing females in gynecology clinics: Lessons learned from a pilot survey.
    PLoS One. 2020;15:e0238710.
    PubMed     Abstract available

  234. CHAUHAN AS, Prinja S, Srinivasan R, Rai B, et al
    Cost effectiveness of strategies for cervical cancer prevention in India.
    PLoS One. 2020;15:e0238291.
    PubMed     Abstract available

  235. FERREYRA C, Osborn J, Moussy F, Alirol E, et al
    Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.
    PLoS One. 2020;15:e0237424.
    PubMed     Abstract available

  236. GOMES JM, Silva BM, Santos EFS, Kelly PJ, et al
    Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance.
    PLoS One. 2020;15:e0241674.
    PubMed     Abstract available

  237. SILVA AAO, de Oliveira UD, Vasconcelos LCM, Foti L, et al
    Correction: Performance of Treponema pallidum recombinant proteins in the serological diagnosis of syphilis.
    PLoS One. 2020;15:e0242386.
    PubMed     Abstract available

  238. Correction: Long-term protection of HPV test in women at risk of cervical cancer.
    PLoS One. 2020;15:e0243000.
    PubMed     Abstract available

  239. GONCALVES A, Soper B, Nygard M, Nygard JF, et al
    Improving five-year survival prediction via multitask learning across HPV-related cancers.
    PLoS One. 2020;15:e0241225.
    PubMed     Abstract available

  240. KENGNE-NDE C, de Dieu Anoubissi J, Loni-Ekali G, Nguefeu-Nkenfou C, et al
    Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis.
    PLoS One. 2020;15:e0241999.
    PubMed     Abstract available

  241. ZHANG H, Deng X, Cui B, Shao Z, et al
    Abortion and various associated risk factors in dairy cow and sheep in Ili, China.
    PLoS One. 2020;15:e0232568.
    PubMed     Abstract available

  242. CHARALAMBOUS R, Narayan E
    A 29-year retrospective analysis of koala rescues in New South Wales, Australia.
    PLoS One. 2020;15:e0239182.
    PubMed     Abstract available

  243. MANATHUNGE A, Barbaric J, Mestrovic T, Beneragama S, et al
    HIV prevalence, sexual risk behaviours and HIV testing among female sex workers in three cities in Sri Lanka: Findings from respondent-driven sampling surveys.
    PLoS One. 2020;15:e0239951.
    PubMed     Abstract available

  244. MEGERSA BS, Bussmann H, Barnighausen T, Muche AA, et al
    Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
    PLoS One. 2020;15:e0243036.
    PubMed     Abstract available

  245. TOUNKARA FK, Teguete I, Guedou FA, Goma-Matsetse E, et al
    Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa.
    PLoS One. 2020;15:e0242711.
    PubMed     Abstract available

  246. CASPE SG, Livingstone M, Frew D, Aitchison K, et al
    The 1B vaccine strain of Chlamydia abortus produces placental pathology indistinguishable from a wild type infection.
    PLoS One. 2020;15:e0242526.
    PubMed     Abstract available

  247. TJAGUR S, Mandar R, Punab M
    Profile of sexually transmitted infections causing urethritis and a related inflammatory reaction in urine among heterosexual males: A flow-cytometry study.
    PLoS One. 2020;15:e0242227.
    PubMed     Abstract available

  248. CHUERDUANGPHUI J, Ekalaksananan T, Heawchaiyaphum C, Vatanasapt P, et al
    Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
    PLoS One. 2020;15:e0242465.
    PubMed     Abstract available

  249. TAKU O, Meiring TL, Gustavsson I, Phohlo K, et al
    Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa.
    PLoS One. 2020;15:e0241781.
    PubMed     Abstract available

  250. PATIL S, Rao A, Pathak P, Kurle S, et al
    Unsterile injection equipment associated with HIV outbreak and an extremely high prevalence of HCV-A case-control investigation from Unnao, India.
    PLoS One. 2020;15:e0243534.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.